pdt01
Major Protocol Deviations Table.
pdt01.Rd
A major protocol deviations table with the number of subjects and the total number of treatments by medication class sorted alphabetically and medication name sorted by frequencies.
Usage
pdt01_main(
adam_db,
arm_var = "ARM",
lbl_overall = NULL,
dvcode_var = "DVDECOD",
dvterm_var = "DVTERM",
...
)
pdt01_pre(adam_db, ...)
pdt01_post(
tlg,
prune_0 = TRUE,
dvcode_var = "DVDECOD",
dvterm_var = "DVTERM",
...
)
pdt01
Arguments
- adam_db
(
list
ofdata.frames
) object containing theADaM
datasets- arm_var
(
string
) variable used for column splitting- lbl_overall
(
string
) label used for overall column, if set toNULL
the overall column is omitted- dvcode_var
(
string
) the variable defining the protocol deviation coded term. By defaultDVDECOD
.- dvterm_var
(
string
) the variable defining the protocol deviation term. By defaultDVTERM
.- ...
not used.
- tlg
(
TableTree
,Listing
orggplot
) object typically produced by amain
function.- prune_0
(
flag
) remove 0 count rows
Details
Data should be filtered for major protocol deviations.
(DVCAT == "MAJOR")
.Numbers represent absolute numbers of subjects and fraction of
N
, or absolute numbers when specified.Remove zero-count rows unless overridden with
prune_0 = FALSE
.Split columns by arm.
Does not include a total column by default.
Sort by medication class alphabetically and within medication class by decreasing total number of patients with the specific medication.
Note
adam_db
object must contain anaddv
table with the columns specified indvcode_var
anddvterm_var
as well as"DVSEQ"
.
Examples
run(pdt01, syn_data)
#> Category A: Drug X B: Placebo C: Combination
#> Description (N=134) (N=134) (N=132)
#> ——————————————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one major protocol deviation 22 (16.4%) 23 (17.2%) 13 (9.8%)
#> Total number of major protocol deviations 40 42 21
#> EXCLUSION CRITERIA
#> Active or untreated or other excluded cns metastases 5 (3.7%) 3 (2.2%) 0
#> Pregnancy criteria 2 (1.5%) 4 (3.0%) 0
#> History of other malignancies within the last 5 years 3 (2.2%) 2 (1.5%) 0
#> Uncontrolled concurrent condition 3 (2.2%) 1 (0.7%) 0
#> Other exclusion criteria 0 0 3 (2.3%)
#> Received prior prohibited therapy or medication 0 2 (1.5%) 1 (0.8%)
#> INCLUSION CRITERIA
#> No signed ICF at study entry 6 (4.5%) 4 (3.0%) 0
#> Ineligible cancer type or current cancer stage 6 (4.5%) 1 (0.7%) 1 (0.8%)
#> Inclusion lab values outside allowed limits 0 3 (2.2%) 0
#> Does not meet prior therapy requirements 1 (0.7%) 0 0
#> Inclusion-related test not done/out of window 0 0 1 (0.8%)
#> MEDICATION
#> Significant deviation from planned dose 3 (2.2%) 1 (0.7%) 2 (1.5%)
#> Received incorrect study medication 1 (0.7%) 2 (1.5%) 1 (0.8%)
#> Discontinued study drug for unspecified reason 1 (0.7%) 1 (0.7%) 1 (0.8%)
#> Dose missed or significantly out of window 2 (1.5%) 0 1 (0.8%)
#> Received prohibited concomitant medication 0 2 (1.5%) 0
#> PROCEDURAL
#> Eligibility-related test not done/out of window 1 (0.7%) 6 (4.5%) 1 (0.8%)
#> Omission of screening tumor assessment 0 4 (3.0%) 3 (2.3%)
#> Missed assessment affecting safety/study outcomes 1 (0.7%) 2 (1.5%) 2 (1.5%)
#> Failure to sign updated ICF within two visits 2 (1.5%) 1 (0.7%) 1 (0.8%)
#> Missed 2 or more efficacy assessments 2 (1.5%) 0 1 (0.8%)
#> Omission of complete lab panel required by protocol 0 1 (0.7%) 1 (0.8%)